ALB
Get informed when a big investor buys or sells
+ FollowMay 7, 2026 - AI Summary
Overvalued by 174% based on the discounted cash flow analysis.
| Market cap | $11.11 Billion |
|---|---|
| Enterprise Value | $11.60 Billion |
| Dividend Yield | $1.63 (1.73%) |
| Earnings per Share | $-5.75 |
| Beta | 1.36 |
| Outstanding Shares | 117,961,000 |
| P/E Ratio | 195.15 |
|---|---|
| PEG | 9.78 |
| Price to Sales | 1.87 |
| Price to Book Ratio | 1.06 |
| Enterprise Value to Revenue | 1.96 |
| Enterprise Value to EBIT | 25.96 |
| Enterprise Value to Net Income | 82 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 135.92% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | 367,800▼ 95.93% |
Holdings and activity of institutional investors.
| Ownership % | 0.69%▼ 98.38% |
|---|---|
| Total Invested | $84.49M▼ 99.46% |
| Investors Holding | 89▼ 938.00% |
No data
Albemarle Corporation is a global enterprise dedicated to the creation, production, and distribution of advanced specialty chemicals. The company's operations are divided into three principal divisions: Lithium, Bromine, and Catalysts. T...